Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 19,228.0 | 14,964.0 | 11,423.0 | 12,168.0 | 14,212.0 | 12,607.0 | 10,630.0 | 10,337.0 |
| Revenue growth | 28.5% | 31.0% | -6.1% | -14.4% | 12.7% | 18.6% | 2.8% | -16.0% |
| Cost of goods sold | 15,560.0 | 11,628.0 | 8,144.0 | 9,149.0 | 11,062.0 | 9,434.0 | 7,791.0 | 3,066.0 |
| Gross profit | 3,668.0 | 3,336.0 | 3,279.0 | 3,019.0 | 3,150.0 | 3,173.0 | 2,839.0 | 7,271.0 |
| Gross margin | 19.1% | 22.3% | 28.7% | 24.8% | 22.2% | 25.2% | 26.7% | 70.3% |
| Selling, general and administrative | | | | | | | | |
| General and administrative | 457.0 | 431.0 | 395.0 | 406.0 | 405.0 | 391.0 | 370.0 | 364.0 |
| EBITA | 1,759.0 | 1,544.0 | 1,608.0 | 1,564.0 | 1,648.0 | 1,781.0 | 1,509.0 | 1,144.0 |
| EBITA margin | 9.1% | 10.3% | 14.1% | 12.9% | 11.6% | 14.1% | 14.2% | 11.1% |
| Amortization of intangibles | 16.0 | 16.0 | 16.0 | 9.0 | 27.0 | 29.0 | 16.0 | 11.0 |
| EBIT | 1,743.0 | 1,528.0 | 1,592.0 | 1,555.0 | 1,621.0 | 1,752.0 | 1,493.0 | 1,133.0 |
| EBIT margin | 9.1% | 10.2% | 13.9% | 12.8% | 11.4% | 13.9% | 14.0% | 11.0% |
| Pre-tax income | 1,112.0 | 656.0 | 1,082.0 | 1,013.0 | 1,216.0 | 1,287.0 | 1,105.0 | 950.0 |
| Income taxes | 29.0 | -130.0 | 37.0 | 71.0 | 98.0 | 175.0 | 271.0 | 230.0 |
| Tax rate | 2.6% | | 3.4% | 7.0% | 8.1% | 13.6% | 24.5% | 24.2% |
| Earnings from continuing ops | 1,083.0 | 786.0 | 1,045.0 | 942.0 | 0.0 | 0.0 | 868.0 | 727.0 |
| Earnings from discontinued ops | | 117.0 | 326.0 | 230.0 | | | | |
| Net income | 1,083.0 | 903.0 | 1,371.0 | 1,172.0 | 0.0 | 0.0 | 868.0 | 727.0 |
| Net margin | 5.6% | 6.0% | 12.0% | 9.6% | 0.0% | 0.0% | 8.2% | 7.0% |
| |
| Diluted EPS | $5.53 | $4.05 | $5.41 | $5.09 | $0.00 | $0.00 | $4.85 | $4.06 |
| Shares outstanding (diluted) | 196.0 | 194.0 | 193.0 | 185.0 | 0.2 | 0.2 | 179.0 | 179.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|